Navigation Links
Surgeon General's 'Call to Action' to Prevent DVT/PE Praised by NATT as Turning Point

TARRYTOWN, N.Y., Sept. 15 /PRNewswire-USNewswire/ -- The National Alliance for Thrombosis and Thrombophilia (NATT) praised Acting Surgeon General Rear Admiral Steven K. Galson, MD, MPH for issuing an historic "Call to Action" (CTA) to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).

RADM Galson presented the CTA this morning in Washington DC ( on-dvt-2008.pdf ). Dr. Galson called for "the development of a coordinated strategy to improve awareness of DVT and PE," pointing out that blood clots "contribute to at least 100,000 deaths each year."

"Today will be forever remembered as the turning point in the battle against blood clots," said NATT President Randy Fenninger. "NATT is committed to working aggresively to build on the momentum of this important CTA.

NATT is executing a strategic plan of awareness and education (consumers, patients and health professionals), outreach, advocacy and support towards achieving the goals of the CTA.

Blood clots are far more frequent than most people understand because they are often secondary to other other underlying illnesses or conditions. For example, some of those most vulnerable to DVT/PEs include people being hospitalized, undergoing major surgery (e.g. hip or knee replacement) or living in nursing homes. Others at risk include people with cancer, travellers on long trips (e.g. train, airplane), older age, obesity, women on hormone replacement therapy, birth control (pills, patch, ring) or pregnancy/recently gave birth or genetic/hereditary or acquired blood clotting disorder.

NATT Medical Director Stephan Moll, MD said "the CTA underscores the public health urgency of preventing the hundreds of thousands of deaths and DVT/PEs that occur each year."

In cooperation with the Centers for Disease Control, NATT will be convening "Stop the Clot Forums" for patient and consumer education:

-- October 4 - Minneapolis, MN

-- October 18 - Baltimore, MD

-- November 22 - Raleigh-Durham, NC

In the past year, CDC has designated thrombosis as a priority, increasing surveillance of DVT/PE in the US and entering into a cooperative agreement with NATT to educate patients, the public and healthcare professionals. In August, The Center for Medicare and Medicaid Services issued final regulations that recognizes DVT/PE as Hospital Acquired Conditions for patients undergoing hip/knee replacement surgery because, with proper prophylaxis, DVT/PE can be prevented most of the time.


Alan Brownstein


SOURCE National Alliance for Thrombosis and Thrombophilia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
2. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
3. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
4. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
5. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
6. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
7. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
8. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
9. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
10. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
11. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):